The store will not work correctly when cookies are disabled.
3-(6-Amino-purin-9-yl)-4-phenyl-butan-2-ol
ID: ALA341027
PubChem CID: 10016680
Max Phase: Preclinical
Molecular Formula: C15H17N5O
Molecular Weight: 283.33
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(O)C(Cc1ccccc1)n1cnc2c(N)ncnc21
Standard InChI: InChI=1S/C15H17N5O/c1-10(21)12(7-11-5-3-2-4-6-11)20-9-19-13-14(16)17-8-18-15(13)20/h2-6,8-10,12,21H,7H2,1H3,(H2,16,17,18)
Standard InChI Key: SSMBCMXVNGQHJG-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
3.3042 -6.2500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5167 -6.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5167 -5.1750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3000 -4.9167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7792 -5.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5542 -7.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8042 -4.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7917 -6.4167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0875 -5.1667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0792 -5.9917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0042 -7.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3667 -7.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8042 -3.9375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1792 -7.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6250 -7.9875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9167 -6.5875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7667 -6.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7667 -8.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9417 -8.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9417 -6.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5292 -7.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 2 0
4 5 2 0
5 1 1 0
1 6 1 0
7 3 1 0
8 2 1 0
9 10 1 0
10 8 2 0
11 6 1 0
12 6 1 0
13 7 1 0
14 11 1 0
12 15 1 0
16 12 1 0
17 14 2 0
18 14 1 0
19 18 2 0
20 17 1 0
21 19 1 0
3 4 1 0
9 7 2 0
21 20 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 283.33 | Molecular Weight (Monoisotopic): 283.1433 | AlogP: 1.57 | #Rotatable Bonds: 4 |
Polar Surface Area: 89.85 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.70 | CX LogP: 1.49 | CX LogD: 1.49 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.76 | Np Likeness Score: -0.27 |
References
1. Zhao YZ, van Breemen RB, Nikolic D, Huang CR, Woodbury CP, Schilling A, Venton DL.. (1997) Screening solution-phase combinatorial libraries using pulsed ultrafiltration/electrospray mass spectrometry., 40 (25): [PMID:9406591] [10.1021/jm960729b] |